^
Association details:
| Biomarker: | miR-142 overexpression |
|---|---|
| Cancer: | Triple Negative Breast Cancer |
| Drug: | paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway
Published date:
03/01/2021
Excerpt:
...the overall survival of TNBC patients with high expression of miR-142 was significantly better than that of patients with low expression of miR-142...
DOI:
10.1186/s12943-021-01332-8
